148 related articles for article (PubMed ID: 26201800)
1. p53 codon 72 polymorphism and hepatocellular carcinoma: a meta-analysis.
Jia S; Tang W; Luo Y
Hepatol Int; 2013 Jun; 7(2):669-75. PubMed ID: 26201800
[TBL] [Abstract][Full Text] [Related]
2. p53 codon 72 polymorphism and endometriosis: a meta-analysis.
Jia S; Xu L; Chan Y; Wu X; Yang S; Yu H; Yang H; Luo Y; Tang W
Arch Gynecol Obstet; 2012 Jun; 285(6):1657-61. PubMed ID: 22258307
[TBL] [Abstract][Full Text] [Related]
3. Association of p53 Arg72Pro polymorphism with esophageal cancer: a meta-analysis based on 14 case-control studies.
Zhao L; Zhao X; Wu X; Tang W
Genet Test Mol Biomarkers; 2013 Oct; 17(10):721-6. PubMed ID: 23844939
[TBL] [Abstract][Full Text] [Related]
4. p53 codon 72 polymorphism and breast cancer risk: A meta-analysis.
Hou J; Jiang Y; Tang W; Jia S
Exp Ther Med; 2013 May; 5(5):1397-1402. PubMed ID: 23737888
[TBL] [Abstract][Full Text] [Related]
5. The association between polymorphism of P53 codon 72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3704 cases.
Hu S; Zhao L; Yang J; Hu M
Meta Gene; 2013 Dec; 1():126-37. PubMed ID: 25606382
[TBL] [Abstract][Full Text] [Related]
6. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.
Lv L; Wang P; Zhou X; Sun B
Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481
[TBL] [Abstract][Full Text] [Related]
7. Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk: A MOOSE-compliant meta-analysis.
Duan X; Li J
Medicine (Baltimore); 2017 Sep; 96(36):e7856. PubMed ID: 28885338
[TBL] [Abstract][Full Text] [Related]
8. Homozygosity for Pro of p53 Arg72Pro as a potential risk factor for hepatocellular carcinoma in Chinese population.
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
World J Gastroenterol; 2005 Jan; 11(2):289-92. PubMed ID: 15633234
[TBL] [Abstract][Full Text] [Related]
9. p53 codon 72 polymorphism and recurrent pregnancy loss: a meta-analysis.
Tang W; Zhou X; Chan Y; Wu X; Luo Y
J Assist Reprod Genet; 2011 Sep; 28(10):965-9. PubMed ID: 21842249
[TBL] [Abstract][Full Text] [Related]
10. Association between p53 Arg72Pro polymorphism and recurrent pregnancy loss: an updated systematic review and meta-analysis.
Chen H; Yang X; Wang Z
Reprod Biomed Online; 2015 Aug; 31(2):149-53. PubMed ID: 26099444
[TBL] [Abstract][Full Text] [Related]
11. The association between polymorphism of P53 Codon72 Arg/Pro and hepatocellular carcinoma susceptibility: evidence from a meta-analysis of 15 studies with 3,704 cases.
Hu S; Zhao L; Yang J; Hu M
Tumour Biol; 2014 Apr; 35(4):3647-56. PubMed ID: 24326769
[TBL] [Abstract][Full Text] [Related]
12. [p53 gene codon 72 polymorphism and genetic susceptibility to hepatocellular carcinoma in Chinese population].
Zhu ZZ; Cong WM; Liu SF; Dong H; Zhu GS; Wu MC
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):76-9. PubMed ID: 15774209
[TBL] [Abstract][Full Text] [Related]
13. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM
Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333
[TBL] [Abstract][Full Text] [Related]
14. Association of p53 Arg72Pro polymorphism with gastric cancer: a meta-analysis.
Tang W; Zhou X; Nie S; Yang Z; Zhu H; Wu X; Zhao R; Luo Y
Biomarkers; 2012 Nov; 17(7):597-603. PubMed ID: 22780299
[TBL] [Abstract][Full Text] [Related]
15. P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility.
Hou J; Gu Y; Hou W; Wu S; Lou Y; Yang W; Zhu L; Hu Y; Sun M; Xue H
BMC Genet; 2015 Jun; 16():72. PubMed ID: 26123760
[TBL] [Abstract][Full Text] [Related]
16. Lack of association between p53 codon 72 polymorphism and endometrial cancer: a meta-analysis.
Tang W; He X; Chan Y; Luo Y
Cancer Epidemiol; 2012 Jun; 36(3):e153-7. PubMed ID: 22277327
[TBL] [Abstract][Full Text] [Related]
17. No Evidence of Association of the Arg72Pro p53 Gene Polymorphism with Cancer Risk in the Saudi Population: a Meta-Analysis.
Irshad M; Mandal RK; Al-Drees A; Khalil MS; Abdulghani HM
Asian Pac J Cancer Prev; 2015; 16(14):5663-7. PubMed ID: 26320432
[TBL] [Abstract][Full Text] [Related]
18. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Yoon YJ; Chang HY; Ahn SH; Kim JK; Park YK; Kang DR; Park JY; Myoung SM; Kim DY; Chon CY; Han KH
Carcinogenesis; 2008 Jun; 29(6):1192-6. PubMed ID: 18390844
[TBL] [Abstract][Full Text] [Related]
19. The Pro variant of the p53 codon 72 polymorphism is associated with hepatocellular carcinoma in Moroccan population.
Ezzikouri S; El Feydi AE; Chafik A; Benazzouz M; El Kihal L; Afifi R; Hassar M; Pineau P; Benjelloun S
Hepatol Res; 2007 Sep; 37(9):748-54. PubMed ID: 17573955
[TBL] [Abstract][Full Text] [Related]
20. P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis.
He F; Xia Y; Liu H; Li J; Wang C
Tumour Biol; 2013 Oct; 34(5):3121-30. PubMed ID: 23860773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
